Sheldon Greer

1.5k total citations
40 papers, 1.3k citations indexed

About

Sheldon Greer is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Sheldon Greer has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Epidemiology. Recurrent topics in Sheldon Greer's work include Biochemical and Molecular Research (12 papers), Cancer, Hypoxia, and Metabolism (10 papers) and RNA modifications and cancer (6 papers). Sheldon Greer is often cited by papers focused on Biochemical and Molecular Research (12 papers), Cancer, Hypoxia, and Metabolism (10 papers) and RNA modifications and cancer (6 papers). Sheldon Greer collaborates with scholars based in United States, France and Denmark. Sheldon Greer's co-authors include Stephen Zamenhof, David A. Boothman, Geoffrey M. Cooper, Michael J. Dobersen, Thomas V. Briggle, Víctor E. Márquez, Daniel J. Weisenberger, Thomas Thykjær, Torben F. Ørntoft and Jonathan Cheng and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Sheldon Greer

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheldon Greer United States	20	899	223	158	146	121	40	1.3k
Giovanni Ciarrocchi Italy	24	1.1k 1.3×	224 1.0×	132 0.8×	139 1.0×	137 1.1×	70	1.5k
J. Coppey France	20	665 0.7×	281 1.3×	88 0.6×	191 1.3×	176 1.5×	63	1.3k
Kazunobu Miura Japan	14	1.4k 1.5×	169 0.8×	93 0.6×	85 0.6×	117 1.0×	46	1.8k
Bruce E. Kaplan United States	23	1.8k 2.0×	144 0.6×	101 0.6×	117 0.8×	288 2.4×	29	2.2k
C K Mathews United States	26	1.4k 1.6×	127 0.6×	98 0.6×	228 1.6×	315 2.6×	51	1.9k
Rafael Molina Spain	21	1.0k 1.1×	311 1.4×	163 1.0×	152 1.0×	176 1.5×	71	1.6k
Paul S. Miller United States	26	1.7k 1.9×	202 0.9×	147 0.9×	84 0.6×	105 0.9×	49	1.9k
S. Rajagopalan United States	20	1.1k 1.2×	381 1.7×	114 0.7×	96 0.7×	175 1.4×	33	1.4k
Daniel Barsky United States	20	1.0k 1.2×	146 0.7×	81 0.5×	211 1.4×	141 1.2×	32	1.7k
Darrell R. Davis United States	23	1.8k 2.1×	177 0.8×	118 0.7×	134 0.9×	109 0.9×	49	2.2k

Countries citing papers authored by Sheldon Greer

Since Specialization

Citations

This map shows the geographic impact of Sheldon Greer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Greer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Greer more than expected).

Fields of papers citing papers by Sheldon Greer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon Greer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Greer. The network helps show where Sheldon Greer may publish in the future.

Co-authorship network of co-authors of Sheldon Greer

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon Greer. A scholar is included among the top collaborators of Sheldon Greer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon Greer. Sheldon Greer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Greer, Sheldon, et al.. (2016). Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic. Anti-Cancer Agents in Medicinal Chemistry. 17(2). 250–264. 4 indexed citations

2.

Li, Long Shan, Julio C. Morales, Martina Veigl, et al.. (2009). DNA mismatch repair (MMR)‐dependent 5‐fluorouracil cytotoxicity and the potential for new therapeutic targets. British Journal of Pharmacology. 158(3). 679–692. 60 indexed citations

3.

Cheng, Jonathan, Christine B. Yoo, Daniel J. Weisenberger, et al.. (2004). Preferential response of cancer cells to zebularine. Cancer Cell. 6(2). 151–158. 254 indexed citations

4.

Greer, Sheldon, et al.. (2001). Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude mice 1 1This paper is dedicated to the memory of Dr. Stephen Zamenhof, the postdoctoral mentor and source of inspiration to S. Greer, and to the memory of Stanley Marion, a devoted and skilled veterinary technician.. International Journal of Radiation Oncology*Biology*Physics. 51(3). 791–806. 11 indexed citations

5.

Greer, Sheldon, et al.. (1995). Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation. International Journal of Radiation Oncology*Biology*Physics. 32(4). 1059–1069. 12 indexed citations

6.

Greer, Sheldon, et al.. (1992). 5-Chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice. International Journal of Radiation Oncology*Biology*Physics. 22(3). 505–510. 6 indexed citations

7.

Santos, Orlando David Henrique dos, et al.. (1990). Radiation, pool size and incorporation studies in mice with 5-chloro-2′-deoxycytidine. International Journal of Radiation Oncology*Biology*Physics. 19(2). 357–365. 14 indexed citations

8.

Boothman, David A., Thomas V. Briggle, & Sheldon Greer. (1989). Exploitation of elevated pyrimidine deaminating enzymes for selective chemotherapy. Pharmacology & Therapeutics. 42(1). 65–88. 18 indexed citations

9.

Boothman, David A., Thomas V. Briggle, & Sheldon Greer. (1987). Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.. PubMed. 47(9). 2354–62. 19 indexed citations

10.

Boothman, David A., et al.. (1985). Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.. PubMed. 45(11 Pt 1). 5270–80. 16 indexed citations

11.

Boothman, David A., et al.. (1984). Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.. PubMed. 44(6). 2551–60. 21 indexed citations

12.

Fox, Lawrence, Michael J. Dobersen, & Sheldon Greer. (1983). Incorporation of 5-Substituted Analogs of Deoxycytidine into DNA of Herpes Simplex Virus-Infected or -Transformed Cells Without Deamination to the Thymidine Analog. Antimicrobial Agents and Chemotherapy. 23(3). 465–476. 22 indexed citations

13.

Fox, Lawrence, Michael J. Dobersen, & Sheldon Greer. (1983). Incorporation of 5-Substituted Analogs of Deoxycytidine into DNA of Herpes Simplex Virus-Infected or -Transformed Cells Without Deamination to the Thymidine Analog. Antimicrobial Agents and Chemotherapy. 24(1). 140–140. 2 indexed citations

14.

Dobersen, Michael J., et al.. (1980). Inhibition of the Replication of Human Cytomegalovirus by Bromodeoxycytidine in the Absence of Detectable Increases in Bromodeoxycytidine Kinase Activity. Intervirology. 14(5-6). 233–238. 3 indexed citations

15.

Greer, Sheldon, et al.. (1978). Host-cell reactivation of UV-irradiated and chemically-treated herpes simplex virus-1 by xeroderma pigmentosum, XP heterozygotes and normal skin fibroblasts. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 50(3). 395–405. 19 indexed citations

16.

Dobersen, Michael J. & Sheldon Greer. (1978). Herpes simplex virus type 2 induced pyrimidine nucleoside kinase: enzymic basis for the selective antiherpetic effect of 5-halogenated analogs of deoxycytidine. Biochemistry. 17(5). 920–928. 24 indexed citations

17.

Cooper, Geoffrey M. & Sheldon Greer. (1973). The Effect of Inhibition of Cytidine Deaminase by Tetrahydrouridine on the Utilization of Deoxycytidine and 5-Bromodeoxycytidine for Deoxyribonucleic Acid Synthesis. Molecular Pharmacology. 9(6). 698–703. 20 indexed citations

18.

Cooper, Geoffrey M. & Sheldon Greer. (1973). Phosphorylation of 5-Halogenated Deoxycytidine Analogues by Deoxycytidine Kinase. Molecular Pharmacology. 9(6). 704–710. 23 indexed citations

19.

Cooper, Geoffrey M., W. F. Dunning, & Sheldon Greer. (1972). Role of catabolism in pyrimidine utilization for nucleic acid synthesis in vivo.. PubMed. 32(2). 390–7. 38 indexed citations

20.

Cooper, Geoffrey M. & Sheldon Greer. (1970). Irreversible inhibition of dehalogenation of 5-iodouracil by 5-diazouracil and reversible inhibition by 5-cyanouracil.. PubMed. 30(12). 2937–41. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact